A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants

Clinical trial NCT02624986 · TERMINATED

Trial details

NCT number: NCT02624986
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2015-12-23
Primary completion: 2019-05-20
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.